Viewing StudyNCT02713295



Ignite Creation Date: 2024-05-06 @ 8:19 AM
Last Modification Date: 2024-10-26 @ 11:58 AM
Study NCT ID: NCT02713295
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2016-03-15

Brief Title: A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
Sponsor: AbbVie
Organization: AbbVie

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-06-16
Start Date Type: ACTUAL
Primary Completion Date: 2019-04-19
Primary Completion Date Type: ACTUAL
Completion Date: 2019-04-19
Completion Date Type: ACTUAL
First Submit Date: 2016-03-15
First Submit QC Date: March 15 2016
Study First Post Date: 2016-03-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-04-14
Last Update Post Date: 2020-04-15
Last Update Post Date Type: ACTUAL